Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Bumhee | - |
dc.contributor.author | Jhun, Byung Woo | - |
dc.contributor.author | Moon, Seong Mi | - |
dc.contributor.author | Lee, Hyun | - |
dc.contributor.author | Park, Hye Yun | - |
dc.contributor.author | Jeon, Kyeongman | - |
dc.contributor.author | Kim, Dae Hun | - |
dc.contributor.author | Kim, Su-Young | - |
dc.contributor.author | Shin, Sung Jae | - |
dc.contributor.author | Daley, Charles L. | - |
dc.contributor.author | Koh, Won-Jung | - |
dc.date.accessioned | 2021-07-30T05:12:11Z | - |
dc.date.available | 2021-07-30T05:12:11Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 0066-4804 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3523 | - |
dc.description.abstract | Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effectiveness for this disease. This study sought to evaluate the clinical efficacy of a CFZ-containing regimen for the treatment of M. abscessus lung disease. We performed a retrospective review of the medical records of 42 patients with M. abscessus lung disease who were treated with CFZ-containing regimens between November 2013 and January 2015. CFZ was administered in combination with other antibiotics as an initial antibiotic regimen in 15 (36%) patients (initial treatment group), and it was added to an existing antibiotic regimen for refractory M. abscessus lung disease in 27 (64%) patients (salvage treatment group). Overall, there was an 81% treatment response rate based on symptoms and a 31% response rate based on radiographic findings. Conversion to culture-negative sputum samples was achieved in 10 (24%) patients after CFZ-containing antibiotic treatment, and during treatment, there were significant decreases in the positivity of semi-quantitative sputum cultures for acid-fast bacilli in both the initial (P = 0.018) and salvage (P = 0.001) treatment groups. Our study suggests that CFZ-containing regimens may improve treatment outcomes in patients with M. abscessus lung disease and that a prospective evaluation of CFZ in M. abscessus lung disease is warranted. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER SOC MICROBIOLOGY | - |
dc.title | Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Hyun | - |
dc.identifier.doi | 10.1128/AAC.02052-16 | - |
dc.identifier.scopusid | 2-s2.0-85019694371 | - |
dc.identifier.wosid | 000403783400075 | - |
dc.identifier.bibliographicCitation | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, v.61, no.6, pp.1 - 9 | - |
dc.relation.isPartOf | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | - |
dc.citation.title | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | - |
dc.citation.volume | 61 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | MULTIDRUG-RESISTANT TUBERCULOSIS | - |
dc.subject.keywordPlus | PULMONARY-DISEASE | - |
dc.subject.keywordPlus | NONTUBERCULOUS MYCOBACTERIA | - |
dc.subject.keywordPlus | TREATMENT OUTCOMES | - |
dc.subject.keywordPlus | RESPIRATORY SPECIMENS | - |
dc.subject.keywordPlus | CLINICAL-SIGNIFICANCE | - |
dc.subject.keywordPlus | ANTIBIOTIC-TREATMENT | - |
dc.subject.keywordPlus | DRUG-COMBINATION | - |
dc.subject.keywordPlus | SALVAGE THERAPY | - |
dc.subject.keywordPlus | MASSILIENSE | - |
dc.subject.keywordAuthor | nontuberculous mycobacteria | - |
dc.subject.keywordAuthor | Mycobacterium abscessus | - |
dc.subject.keywordAuthor | clofazimine | - |
dc.subject.keywordAuthor | treatment outcome | - |
dc.identifier.url | https://journals.asm.org/doi/10.1128/AAC.02052-16 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.